This is an excellent discussion topic. My take is
Post# of 36537
(Total Views: 334)
Posted On: 05/25/2021 9:54:00 AM
This is an excellent discussion topic. My take is less granular. GNBT is still parent for NGIO and owns ~60% of NGIO + all decision making. How does this not carry GNBT to have a more positive pps? I do get the linear property of GNBT owning A shares, but they still own 60% of the company and have the power to unify shares at any conversion factor they choose at anytime. I would think that we would see a price alignment occur upon IPO or at least after GNBT can submit its next quarterly statement as the value of NGIO will be recognized on its balance sheet.
Current EPS = -.56
# of shares = 114.95MM
NGIO tentative valuation @ $9/share = $500MM
New asset is added to Bal Sheet at $300MM
Less current debt of $64.372MM
New asset provides positive $235,628,000 of new company value.
PPS is $2.05 at minimum.
Concerns: obv this is not yet to the $4 Nasdaq mark, abd so could still be messed with on the OTC, so it’ll be great when NGIO hits $1BB in valuation as it will easily propel GNBT to Nasdaq levels.
Current EPS = -.56
# of shares = 114.95MM
NGIO tentative valuation @ $9/share = $500MM
New asset is added to Bal Sheet at $300MM
Less current debt of $64.372MM
New asset provides positive $235,628,000 of new company value.
PPS is $2.05 at minimum.
Concerns: obv this is not yet to the $4 Nasdaq mark, abd so could still be messed with on the OTC, so it’ll be great when NGIO hits $1BB in valuation as it will easily propel GNBT to Nasdaq levels.
(6)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼